newdrugapprovals.org
NEW PATENT, PONESIMOD, CRYSTAL PHARMATECH, WO 2017107972
NEW PATENT, PONESIMOD, CRYSTAL PHARMATECH, WO 2017107972 Novel crystalline forms I, II and III of ponesimod . Useful as a selective sphingosine-1-phosphate receptor-1 (S1P1) receptor agonist, for …